MYCN and neuroblastoma: Abnormalities in pyrimidine metabolism, which are closely linked to uncontrolled cell proliferation, make DHODH a key contributor to cancer development, particularly in high-risk neuroblastoma, where it is associated with MYCN status (22, 23).